Statistics for Humacyte, (id:8106 HUMA)
Valuation metrics
Market cap
577.72M
Enterprise value
548.21M
Trailing P/E (ttm)
-4.20
Forward P/E
-5.22
PEG ratio
-5.22
Price/Sales (ttm)
Price/Book (mrq)
-8.41
Enterprise Value/Revenue
Enterprise Value/EBITDA
-5.21
Overview
Shares outstanding
128.67M
Float
91.31M
Shares short
17.25M
% Held by insiders
0.27%
% Held by institutions
0.30%
Average volume (10 days)
3.50M
Average volume (90 days)
Price summary
52-Week low
2.43
52-Week high
9.97
52-Week change
42.98%
Beta
1.47
50-Day moving average
5.33
200-Day moving average
5.40
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-53.23%
Return on equity
-817.78%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-105,277,000.00
Net income to common (ttm)
-152,867,008.00
Diluted EPS (ttm)
-1.34
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
20.57M
Total cash per share (mrq)
0.16
Total debt (mrq)
17.52M
Total Debt/Equity (mrq)
-0.27
Current ratio (mrq)
109.90%
Book value per share (mrq)
-0.53
Cash flow
Cash flow statement
-90,599,000.00
Levered free cash flow (LFCF)
-58,331,500.00